Gilead Sciences as of Dec. 31, 2025
Portfolio Holdings for Gilead Sciences
Gilead Sciences holds 6 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcus Biosciences Incorporated (RCUS) | 38.7 | $749M | 31M | 23.83 | |
| Galapagos Nv Spon Adr (GLPG) | 28.4 | $551M | 17M | 32.96 | |
| Arcellx Common Stock (ACLX) | 22.6 | $438M | 6.7M | 65.20 | |
| Assembly Biosciences Com New (ASMB) | 7.9 | $153M | 4.5M | 34.01 | |
| Kyverna Therapeutics (KYTX) | 2.0 | $39M | 4.1M | 9.40 | |
| Xilio Therapeutics (XLO) | 0.3 | $5.8M | 9.1M | 0.64 |
